Iram F Khan

Title: Iram F Khan: Innovator in Immunotherapy

Introduction

Iram F Khan is a prominent inventor based in Seattle, WA (US), known for her significant contributions to the field of immunotherapy. With a total of 3 patents, she has made remarkable strides in developing innovative treatments that harness the power of the immune system.

Latest Patents

One of her latest patents is titled "Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins." This application focuses on plasma cells and plasma cell precursors that express macromolecules, such as proteins or peptides. The invention outlines methods for using and creating these plasma cells, which can be administered for therapeutic purposes. Another notable patent is "Expression of FOXP3 in edited CD34+ cells." This invention involves incorporating a FOXP3 cDNA into a FOXP3 gene or a non-FOXP3 locus to achieve regulated FOXP3 expression in primary human CD34 cells. The application also discusses the use of CRISPR/Cas9 technology for gene regulation and modification.

Career Highlights

Iram F Khan is affiliated with Seattle Children's Hospital, where she continues to advance her research and innovations in immunotherapy. Her work is pivotal in developing new treatment methodologies that can significantly impact patient care.

Collaborations

Throughout her career, Iram has collaborated with esteemed colleagues, including David J Rawlings and Andrew M Scharenberg. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking therapies.

Conclusion

Iram F Khan's contributions to immunotherapy exemplify her dedication to advancing medical science. Her innovative patents and collaborative efforts position her as a leading figure in the field, paving the way for future advancements in therapeutic treatments.